Suzanne Jurriaans

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025.

Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 27, 2026

Feasibility and reliability of decentralized HIV-1 viral load monitoring on self-sampled blood.

Feasibility and reliability of decentralized HIV-1 viral load monitoring on self-sampled blood.

Journal: PloS one

Published: December 10, 2025

SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022 - CORRIGENDUM.

SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022 - CORRIGENDUM.

Journal: Epidemiology and infection

Published: March 31, 2025

SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022.

SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022.

Journal: Epidemiology and infection

Published: January 23, 2025

Enhancing safety of rapid and accurate malaria diagnosis in patients at risk for viral haemorrhagic fever.

Enhancing safety of rapid and accurate malaria diagnosis in patients at risk for viral haemorrhagic fever.

Journal: Malaria journal

Published: January 03, 2025

Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruption.

Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruption.

Journal: AIDS (London, England)

Published: December 17, 2024

Autochthonous Human Babesiosis Caused by Babesia venatorum, the Netherlands.

Autochthonous Human Babesiosis Caused by Babesia venatorum, the Netherlands.

Journal: Emerging infectious diseases

Published: August 22, 2024

Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection.

Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection.

Journal: AIDS (London, England)

Published: September 13, 2023

Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS study.

Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS study.

Journal: Vaccine

Published: July 01, 2022

HIV-1-infection in a man who has sex with men despite self-reported excellent adherence to pre-exposure prophylaxis, the Netherlands, August 2021: be alert to emtricitabine/tenofovir-resistant strain transmission.

HIV-1-infection in a man who has sex with men despite self-reported excellent adherence to pre-exposure prophylaxis, the Netherlands, August 2021: be alert to emtricitabine/tenofovir-resistant strain transmission.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: April 08, 2022

SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June-October 2020.

SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June-October 2020.

Journal: BMJ open

Published: January 07, 2022

Differences in SARS-CoV-2 infections during the first and second wave of SARS-CoV-2 between six ethnic groups in Amsterdam, the Netherlands: A population-based longitudinal serological study.

Differences in SARS-CoV-2 infections during the first and second wave of SARS-CoV-2 between six ethnic groups in Amsterdam, the Netherlands: A population-based longitudinal serological study.

Journal: The Lancet regional health. Europe

Published: December 20, 2021

Showing 1-12 of 39

Last Updated: 09/26/2026